T2 BIOSYSTEMS INC (TTOO)

US89853L3024 - Common Stock

3.33  +0.33 (+11%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
7.19M22.31M28.06M18.13M8.34M
Cost Of Goods
15.36M21.10M20.70M20.68M16.76M
Gross Profit
-8.17M1.20M7.36M-2.55M-8.43M
Operating Expenses
38.98M56.40M50.33M37.71M43.63M
Research and Development
13.25M24.78M21.80M16.92M16.33M
Selling, General, and Administrative Expenses
24.83M30.63M28.53M20.79M27.30M
Operating Income
-47.15M-55.20M-42.97M-40.26M-52.06M
Interest Income/Expense
82.00K-6.84M-6.47M-5.50M-7.35M
Other Income/Expense
-495.00K30.00K210.00K60.00K400.00K
Non Recurring Items
-2.51MN/AN/A-1.10MN/A
Income Before Taxes
-50.08M-62.00M-49.24M-46.80M-59.01M
Net Income
-50.08M-62.33M-49.24M-46.80M-59.01M
EBITDA
-46.29M-54.15M-41.70M-38.55M-49.86M
 
Per Share Data
EPS Diluted Total Ops
-19.19-1.25K-1.64K-2.34K-5.90K
Non GAAP EPS
N/A-1.44K-361.50-23.00-64.50
 
Statistics
Gross Profit Margin
-113.58%5.38%26.23%-14.07%-101.08%
Profit Margin
-696.19%-279.38%-175.48%-258.14%-707.55%
Operating Profit Margin
-655.54%-247.42%-153.14%-222.06%-624.22%

All data in USD

Charts